Search

Biodegradable Holmium-166 Rods

About

Minimally invasive radiotherapy for liver and solid tumours

This biodegradable rod delivers localised Holmium-166 radiation directly into solid tumours while enabling real-time imaging. It retains over 99% of its activity for 200+ hours and shows strong cytotoxicity in liver cancer cells, with minimal damage to surrounding tissue. Made from polycaprolactone and globally accessible isotopes, it avoids surgical removal, lowers systemic toxicity, and reduces healthcare burden. Offering a safer, more scalable approach, this technology modernises cancer care through targeted, minimally invasive radiotherapy

Team


Similiar Projects

AllyCloud

AllyCloud

Harvard University

Smart patch for personalised allergy immunotherapy in children

Atlas

Atlas

University of Illinois at Urbana-Champaign

Low-cost neurosurgical navigation for life-saving brain procedures

Bladder Cancer Brachytherapy

Bladder Cancer Brachytherapy

University of California, Los Angeles

Internal radiotherapy with stabilising bladder balloon

CASPER

CASPER

University of Oxford

Programmable gene-targeting therapy and diagnostics to combat antimicrobial resistance